sameAs
Are membrane proteins favored over cytosolic proteins in TAP-independent processing pathways?An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5Urokinase receptor-deficient mice mount an innate immune response to and clarify respiratory viruses as efficiently as wild-type mice.Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.Generation of MHC class I ligands in the secretory and vesicular pathways.Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.Accumulation of polyubiquitylated proteins in response to Ala-Ala-Phe-chloromethylketone is independent of the inhibition of Tripeptidyl peptidase II.Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.Concerted antigen processing of a short viral antigen by human caspase-5 and -10.Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.Hepatitis C virus replication in Caucasian HIV controllers.Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes.Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.Differential prevalence of the HLA-C −35 CC genotype among viremic long term non-progressor and elite controller HIV+ individualsExogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitopeTLR4-Independent upregulation of activation markers in mouse B lymphocytes infected by HRSVAntigen Processing of a Short Viral Antigen by ProteasomesThe latest killer APVaccine vectors: the bright side of cytomegalovirus
P50
Q26862790-21B7E9AA-5839-4F34-B5F9-375B74BDFE32Q31019004-F0DFD057-57BB-4E4C-BC4D-2E25C83F4B9EQ33536620-EC8AC4F4-53A1-4B24-A885-E12359395350Q34368703-85FC0B00-AC16-4D93-8BD3-3A6E5981D735Q35760842-BE558D3D-8EB7-4078-8A2E-7B2995D381C3Q36483028-3B1D880E-77A9-401F-B4DD-7C6B656D4307Q36932732-60D5DC66-3233-4995-9392-98800916AE6CQ36973687-D5FD7EBD-B321-46A5-BE5E-24D1E1F3BB5EQ37851046-44236D1C-FE90-4D39-A783-7A08CF1C2DADQ38501313-78345A5A-8BD8-4EAE-8750-6926A71BDA28Q39289377-38E18C4B-8890-48E7-8D7C-88BDB3CFA6FBQ39639898-E3F637AF-520B-4832-BE8D-2CAFAF2E4D42Q39692167-9DFCF590-2128-4F82-A4FF-8E248D4BD388Q39799881-29FCA1C5-8E83-45FF-966E-6F65AE895718Q39946447-DB0344EC-1289-4E81-AF67-AC5E9980CB10Q40211477-B00E2E61-09C5-4CB2-A4CC-57A297330E7DQ40331084-6F87CC88-5A52-4CCA-B8FF-239459186011Q41880609-F62A0FE6-B66A-4943-9C03-9F9E4AB59744Q42971836-D8CDC225-D28A-4E30-92C4-FB2CF2B1094DQ43037903-3F7BC600-083C-4C43-BDE2-0C1A9D374B41Q45387210-6F3AA0A2-F2A5-4941-A2DE-104B60CBA54EQ45564955-4F27D6F2-5FCF-43D4-9E57-323EBA6BA2C2Q46503099-B2C5824C-8046-4789-9BFD-D2D16F890F8EQ57259559-E392520B-B393-45E5-B36C-DB4F009FB4A3Q57593699-31A3DCA8-51F5-4BE9-A134-5AE2976E849AQ57593716-1CCE7DB7-2BEE-4154-BFD4-EB08D73545B0Q57593732-B0866738-1282-4955-983C-552EB7C5A300Q57593737-CC4C8401-6080-42FC-94E9-89E4C0004369Q92544665-576B964C-7EAE-4366-B451-13DAAA714109
P50
description
Spaans onderzoekster
@nl
Viróloga e inmunóloga española, investigadora do CSIB
@gl
Viróloga e inmunóloga española, investigadora científica del CSIB
@es
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Margarita Del Val
@ast
Margarita Del Val
@en
Margarita Del Val
@es
Margarita Del Val
@nl
Margarita Del Val
@sl
Margarita del Val Latorre
@ca
Margarita del Val Latorre
@gl
type
label
Margarita Del Val
@ast
Margarita Del Val
@en
Margarita Del Val
@es
Margarita Del Val
@nl
Margarita Del Val
@sl
Margarita del Val Latorre
@ca
Margarita del Val Latorre
@gl
altLabel
Margarita del Val Latorre
@en
Margarita del Val Latorre
@es
Margarita del Val
@es
prefLabel
Margarita Del Val
@ast
Margarita Del Val
@en
Margarita Del Val
@es
Margarita Del Val
@nl
Margarita Del Val
@sl
Margarita del Val Latorre
@ca
Margarita del Val Latorre
@gl
P106
P214
P950
P1053
E-4769-2010
P1477
Margarita del Val Latorre
@es
P1607
P19
P1950
P2031
1985-01-01T00:00:00Z
P21
P214
P27
P31
P3829
P496
0000-0001-6769-4279
P512
P569
1959-01-01T00:00:00Z